Intellia Therapeutics, Inc. (NTLA)
NASDAQ·Healthcare·Biotechnology
$13.74
+5.37%
Mkt Cap $1.96B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $11.98M | $23.02M | +92.10% | -$0.99 | -$0.83 | +16.16% | — | — |
| Q4 2025 Nov 6, 2025 | $12.17M | $13.78M | +13.22% | -$1.02 | -$0.92 | +9.80% | — | — |
| Q3 2025 Aug 7, 2025 | $14.06M | $14.24M | +1.29% | -$1.03 | -$0.99 | +3.88% | — | — |
| Q2 2025 May 8, 2025 | $11.93M | $16.63M | +39.34% | -$1.26 | -$1.10 | +12.70% | — | — |
| Q1 2025 Feb 27, 2025 | $10.86M | $12.87M | +18.54% | -$1.32 | -$1.24 | +6.06% | — | — |
| Q4 2024 Nov 7, 2024 | $8.90M | $9.11M | +2.32% | -$1.37 | -$1.34 | +2.19% | — | — |
| Q3 2024 Aug 8, 2024 | $19.16M | $6.96M | -63.69% | -$1.21 | -$1.31 | -8.26% | — | — |
| Q2 2024 May 9, 2024 | $11.50M | $28.93M | +151.61% | -$1.35 | -$1.06 | +21.48% | — | — |
| Q1 2024 Feb 22, 2024 | $12.83M | $1.92M | -85.06% | -$1.47 | -$1.46 | +0.68% | — | — |
| Q4 2023 Nov 9, 2023 | $12.45M | $11.99M | -3.68% | -$1.52 | -$1.38 | +9.21% | — | — |
| Q3 2023 Aug 3, 2023 | $12.08M | $13.59M | +12.53% | -$1.32 | -$1.40 | -6.06% | — | — |
| Q2 2023 May 4, 2023 | $11.83M | $12.61M | +6.56% | -$1.41 | -$1.17 | +17.02% | — | — |
| Q1 2023 Feb 23, 2023 | $11.33M | $13.57M | +19.76% | -$1.40 | -$1.40 | +0.00% | — | — |
| Q4 2022 Nov 3, 2022 | $11.89M | $13.27M | +11.61% | -$1.31 | -$1.49 | -13.74% | — | — |
| Q3 2022 Aug 4, 2022 | $9.42M | $14.03M | +49.00% | -$1.31 | -$1.33 | -1.53% | — | — |
| Q2 2022 May 5, 2022 | $8.54M | $11.25M | +31.75% | -$1.11 | -$1.96 | -76.58% | — | — |
| Q1 2022 Feb 24, 2022 | $8.26M | $12.85M | +55.57% | -$0.91 | -$1.09 | -19.78% | — | — |
| Q4 2021 Nov 4, 2021 | $9.49M | $7.20M | -24.09% | -$0.85 | -$0.97 | -14.12% | — | — |
| Q3 2021 Aug 5, 2021 | $5.58M | $6.55M | +17.36% | -$0.61 | -$1.01 | -65.57% | — | — |
| Q2 2021 May 6, 2021 | $6.15M | $6.45M | +4.76% | -$0.66 | -$0.69 | -4.55% | — | — |